Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-28

Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol [Phase 3]

View source ↗

Summary

Phase 3 study comparing risperidone to placebo for acute manic episodes in Bipolar I Disorder and assessing maintenance against haloperidol; the trial is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Risperdal (risperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorders, Manic Disorder | Phase 3 | Status: COMPLETED